← Leaderboards
Joshua Tisdell Schiffer
Fred Hutchinson Cancer Center
$7,320,811
Attributed
$15,147,022
Total exposure
9
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.7M · FY2010–25$5M$3.8M$2.5M$1.3M$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$15,147,022 · 9
By mechanism
R01$12,274,471 · 5
U19$1,314,078 · 1
R56$908,973 · 1
K23$640,500 · 1
R13$9,000 · 1
Top collaborators
- Jennifer M Lund8 shared
- Martin Prlic8 shared
- Jackson Orem6 shared
- Warren Phipps6 shared
- Joseph Christopher Mudd3 shared
- Stephen J. Polyak3 shared
- Adam Mitchell Spivak3 shared
Most similar at Fred Hutchinson Cancer Center
Same institution · by research overlap
- Hans-Peter Kiem$98,160,227
- Roland Bruno Walter$12,142,218
- Jackson Orem$1,717,870
- Warren Phipps$6,635,898
- Daniel Blanco-Melo$1,551,984
Others in their field
Top investigators on “Mathematical Model”
- Deborah J Donnell · Fred Hutchinson Cancer Center$140,607,304
- Wafaa M. El-Sadr · Columbia University Health Sciences$91,263,426
- Myron S Cohen · Family Health International$91,263,426
- Gregory D Peterson · University Of Tennessee Knoxville$84,527,696
- Robert A Kamphaus · University Of Washington$83,310,874
- Anders Ryd · Cornell University$79,389,944
Research focus
Mathematical ModelViralKineticsResponseVirusInfectionImmune ResponseCellsBaseDesignCharacteristicsDoseSimplexvirusSourceCd4 Positive T LymphocytesSamplingViral Load ResultPersonsSwabIn VivoImmunologicsTissuesLeadPrevent
Grant awards (33)
Early intervention with anti-proliferative therapy close to ART initiation to limit long-term SIV persistence$846,498
R01 · FY2025 · AI · contact PI
Development of an Oral Pan-Coronavirus Drug Cocktail$672,447
R01 · FY2025 · AI
Development of an Oral Pan-Coronavirus Drug Cocktail$674,611
R01 · FY2024 · AI
Early intervention with anti-proliferative therapy close to ART initiation to limit long-term SIV persistence$624,783
R01 · FY2024 · AI · contact PI
Mathematical modeling of optimal therapeutic combinations for HIV cure$465,886
R01 · FY2024 · AI · contact PI
Early intervention with anti-proliferative therapy close to ART initiation to limit long-term SIV persistence$908,973
R56 · FY2023 · AI · contact PI
Development of an Oral Pan-Coronavirus Drug Cocktail$702,361
R01 · FY2023 · AI
Characterizing determinants of primary KSHV infection among children and adolescents in Uganda$588,810
R01 · FY2023 · CA
Mathematical modeling of optimal therapeutic combinations for HIV cure$465,886
R01 · FY2023 · AI · contact PI
Characterizing determinants of primary KSHV infection among children and adolescents in Uganda$563,827
R01 · FY2022 · CA
Immunoprotective Properties of Tissue-resident Memory T Cells in Mice and Humans within Mucosal Sites$31,293
R01 · FY2022 · AI · contact PI
Characterizing determinants of primary KSHV infection among children and adolescents in Uganda$582,929
R01 · FY2021 · CA
5th Workshop on Viral Dynamics$9,000
R13 · FY2021 · AI · contact PI
Characterizing determinants of primary KSHV infection among children and adolescents in Uganda$1
R01 · FY2021 · CA
Immunoprotective Properties of Tissue-resident Memory T Cells in Mice and Humans within Mucosal Sites$785,945
R01 · FY2020 · AI · contact PI
Immunoprotective Properties of Tissue-resident Memory T Cells in Mice and Humans within Mucosal Sites$662,578
R01 · FY2020 · AI · contact PI
Characterizing determinants of primary KSHV infection among children and adolescents in Uganda$566,520
R01 · FY2020 · CA
Immunoprotective Properties of Tissue-resident Memory T Cells in Mice and Humans within Mucosal Sites$146,402
R01 · FY2020 · AI · contact PI
Immunoprotective Properties of Tissue-resident Memory T Cells in Mice and Humans within Mucosal Sites$819,943
R01 · FY2019 · AI · contact PI
Characterizing determinants of primary KSHV infection among children and adolescents in Uganda$566,361
R01 · FY2019 · CA
Immunoprotective Properties of Tissue-resident Memory T Cells in Mice and Humans within Mucosal Sites$820,522
R01 · FY2018 · AI · contact PI
Establishing microbial and biochemical thresholds for development and persistence$226,902
U19 · FY2018 · AI · contact PI
Immunoprotective Properties of Tissue-resident Memory T Cells in Mice and Humans within Mucosal Sites$830,347
R01 · FY2017 · AI · contact PI
Establishing microbial and biochemical thresholds for development and persistence$372,903
U19 · FY2017 · AI · contact PI
Immunoprotective Properties of Tissue-resident Memory T Cells in Mice and Humans within Mucosal Sites$856,521
R01 · FY2016 · AI · contact PI
Establishing microbial and biochemical thresholds for development and persistence$277,649
U19 · FY2016 · AI · contact PI
Establishing microbial and biochemical thresholds for development and persistence$205,665
U19 · FY2015 · AI · contact PI
Establishing microbial and biochemical thresholds for development and persistence$230,959
U19 · FY2014 · AI · contact PI
Intense Validation of a Mathematical Model of Herpes Simplex Virus-2 Pathogenesis$127,996
K23 · FY2014 · AI · contact PI
Intense Validation of a Mathematical Model of Herpes Simplex Virus-2 Pathogenesis$127,996
K23 · FY2013 · AI · contact PI
Intense Validation of a Mathematical Model of Herpes Simplex Virus-2 Pathogenesis$127,996
K23 · FY2012 · AI · contact PI
Intense Validation of a Mathematical Model of Herpes Simplex Virus-2 Pathogenesis$127,996
K23 · FY2011 · AI · contact PI
Intense Validation of a Mathematical Model of Herpes Simplex Virus-2 Pathogenesis$128,516
K23 · FY2010 · AI · contact PI